Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaoxuan Wang
Observed name:
X L Wang
Institution:
Qilu Hospital of Shandong University
Observed institutions:
Shanghai University of Engineering Science,
Qilu Hospital of Shandong University,
Houston Methodist Research Institute,
Xi'an Jiaotong University
ORCID:
0000-0002-4159-6387
Observed ORCID:
0000-0002-4159-6387
OpenAlex ID:
A5090397364
A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylation
2012
·
Y M Zhang
, B L Dai
, et al.
·
Cell Death and Disease
·
38
PDF
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2023
·
Sunny Mai
, Alan Hodges
, et al.
·
Cancer Research
·
21
PDF
Dual-mode immunotherapy: ultrasound responsive zinc-based nano-contract agents synergistically activate the GAS-STING pathway for enhanced tumor sono-metalloimmunotherapy
2025
·
Xinyu Zeng
, Xiaoxuan Wang
, et al.
·
Ultrasonics Sonochemistry
·
8
Dual-responsive nanoscale ultrasound contrast agent as an oxidative stress amplifier for enhanced DNA damage in BRCA-proficient ovarian cancer
2025
·
Jialu Zhang
, Xiaoxuan Wang
, et al.
·
Materials Today Bio
·
6
Ultrasound-activated metal-polyphenol nanodroplets for tumor cuproptosis
2026
·
Ning Cong
, Lu Guo
, et al.
·
Biomaterials
·
4
Crystallization Resolution of a Racemic Compound (R,S)-Sulpiride Promoted by Chiral Ionic Liquids: Insight into the Effect on Selective Nucleation
2025
·
Yuxu Tao
, Yue Xu
, et al.
·
Crystal Growth & Design
·
4
Ultrasound-responsive nanodroplets activate the Hippo pathway via ROS-MST1-YAP cascade for breast cancer therapy
2026
·
Yuye Fu
, Yading Zhao
, et al.
·
Ultrasonics Sonochemistry
Table S2. Ingenuity Pathway Analysis of LILRB3 antibody treated U937 cells from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2026
·
Sunny Mai
, Alan Hodges
, et al.
Table S1. LILRB1-4 surface expression in AML patient samples from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2026
·
Sunny Mai
, Alan Hodges
, et al.
Table S3. CBC+CMP from LILRB3 CAR T adoptively transferred LILRB3 transgenic mice from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2026
·
Sunny Mai
, Alan Hodges
, et al.
Supplementary Figures from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2026
·
Sunny Mai
, Alan Hodges
, et al.
Ultrasound and ROS-responsive nanodroplets inhibit TCA cycle in hepatocellular carcinoma
2026
·
Ting Zhao
, Lu Guo
, et al.
·
Journal of Nanobiotechnology
Table S1. LILRB1-4 surface expression in AML patient samples from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2025
·
Sunny Mai
, Alan Hodges
, et al.
Supplementary Figures from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2025
·
Sunny Mai
, Alan Hodges
, et al.
PDF
Supplementary Data from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2025
·
Sunny Mai
, Alan Hodges
, et al.
Table S3. CBC+CMP from LILRB3 CAR T adoptively transferred LILRB3 transgenic mice from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2025
·
Sunny Mai
, Alan Hodges
, et al.
Table S2. Ingenuity Pathway Analysis of LILRB3 antibody treated U937 cells from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2025
·
Sunny Mai
, Alan Hodges
, et al.
Table S1. LILRB1-4 surface expression in AML patient samples from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2023
·
Sunny Mai
, Alan Hodges
, et al.
Supplementary Figures from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2023
·
Sunny Mai
, Alan Hodges
, et al.
Data from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2023
·
Sunny Mai
, Alan Hodges
, et al.
Table S3. CBC+CMP from LILRB3 CAR T adoptively transferred LILRB3 transgenic mice from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2023
·
Sunny Mai
, Alan Hodges
, et al.
Supplementary Figures from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2023
·
Sunny Mai
, Alan Hodges
, et al.
Table S3. CBC+CMP from LILRB3 CAR T adoptively transferred LILRB3 transgenic mice from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2023
·
Sunny Mai
, Alan Hodges
, et al.
Table S3. CBC+CMP from LILRB3 CAR T adoptively transferred LILRB3 transgenic mice from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2023
·
Sunny Mai
, Alan Hodges
, et al.
Supplementary Data from LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy
2023
·
Sunny Mai
, Alan Hodges
, et al.
Show more works
View as search
Works count:
32
Citation count:
81
H-index:
4
I10-index:
2
Year
Topic
Type